Clinical Trial of Ezogabine (Retigabine) in ALS Subjects

NCT02450552 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: Ezogabine
DRUG: Placebo

Sponsor

Brian Wainger

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]